Annovis Bio, Inc. ANVS
1.13 USD +0.11 +10.78%
At close · Oct 30
1.12 -0.01 -0.57%
After hours · Oct 30, 7:59 PM ET
- YTD
- -67.34%
- 1 year
- -45.67%
- Open
- 1.02
- Prev close
- 1.02
- Mkt cap
- 48.23M
- Vol
- 1.48M
- Avg vol
- 902.76K
- EPS
- -1.75
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.01
- High
- 1.17
- Forward P/E
- -2.77
- Beta
- 0.00
- Short ratio
- 6.21
- Inst. own
- 8.83%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 7.29
- 200-d avg
- 8.47
- 1y target
- 34.80
MAX chart
Chart tools
Chart is warming up
The all-time price history for ANVS has not been loaded yet. Try again in a moment.
Altman Z-Score
-18.04 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 4
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -2.5×
P/S 0.0×
P/B 4.2×
P/FCF -2.8×
EV/EBITDA -1.8×
EV/Sales 0.0×
FCF Yield -36.0%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -171.2%
ROIC -170.2%
ROA -136.9%
Revenue 0.0%
Operating Income -11.2%
EPS (diluted) 39.4%
Free Cash Flow -17.0%
Current Ratio 5.8×
Quick Ratio 5.8×
Debt / Equity 0.0×
Net Debt / EBITDA 0.7×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31
